Capaccio P, Gaffuri M, Rossi V, Pignataro L
Department of Otolaryngology and Head and Neck Surgery, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milan, Italy.
Department of Biomedical, Surgical, Dental Sciences.
Acta Otorhinolaryngol Ital. 2017 Apr;37(2):122-127. doi: 10.14639/0392-100X-1601.
It has been suggested that a conservative trans-oral approach to proximal and hilo-parenchymal submandibular stones (HPSMS) is a valid alternative to the more frequently used sialadenectomy. The aim of this study was to evaluate the surgical, ultrasonographic and patients' subjective outcomes of results of the trans-oral removal of HPSMS. Between January 2003 and September 2015, sialendoscope-assisted trans-oral surgery was used to remove symptomatic, large (> 7 mm), fixed and palpable HPSMS from 479 patients under general anaesthesia. All patients were followed clinically and ultrasonographically to investigate symptom relief and recurrence of stones, and were telephonically interviewed to assess saliva-related subjective outcomes with a questionnaire. Stones were successfully removed from 472 patients (98.5%); the seven failures (1.5%) concerned pure parenchymal stones. One year after the procedure, 408 patients (85.1%) were symptom free, 59 (12.3%) had recurrent obstructive symptoms and 12 (2.6%) had recurrent infections. Of the 54 patients who developed a recurrent stone (11.2%), 52 underwent a second procedure: 29 interventional sialendoscopies, two sialendoscope-assisted intra-corporeal pneumatic lithotripsy, eight secondary transoral surgery to remove residual stones, six a cycle of extra-corporeal lithotripsy and seven submandibular sialadenectomy. Most patients (75.2%) reported mild surgery-related pain. The symptoms of 454 patients (94.8%) improved after adjunctive treatment and, at the end of follow-up, the affected gland was preserved in 98.5% of patients. A sialendoscope-assisted trans-oral removal of large HPSMS is a safe, effective, conservative surgical procedure, and functional preservation of the main duct and parenchyma of the obstructed gland allows sialendoscopic access through the natural ostium in case of recurrence. Combining a trans-oral approach with other minimally invasive, conservative procedures ensures symptomatic relief and salivary duct system clearance in the majority of patients.
有人提出,对于近端和腮腺实质下的颌下腺结石(HPSMS),采用保守的经口入路是更常用的涎腺切除术的一种有效替代方法。本研究的目的是评估经口切除HPSMS的手术、超声检查及患者主观结果。2003年1月至2015年9月期间,在全身麻醉下,使用涎腺镜辅助经口手术从479例患者中切除有症状、较大(>7mm)、固定且可触及的HPSMS。对所有患者进行临床和超声随访,以调查症状缓解及结石复发情况,并通过电话访谈使用问卷评估与唾液相关的主观结果。结石成功从472例患者(98.5%)中取出;7例失败(1.5%)涉及单纯实质内结石。术后一年,408例患者(85.1%)无症状,59例(12.3%)有复发性梗阻症状,12例(2.6%)有复发性感染。在54例出现复发性结石的患者(11.2%)中,52例接受了二次手术:29例介入性涎腺镜检查、2例涎腺镜辅助体内气压弹道碎石术、8例二次经口手术以清除残留结石、6例体外冲击波碎石术疗程及7例下颌下腺切除术。大多数患者(75.2%)报告有轻度手术相关疼痛。454例患者(94.8%)的症状在辅助治疗后有所改善,随访结束时,98.5%的患者受影响腺体得以保留。涎腺镜辅助经口切除大型HPSMS是一种安全、有效的保守手术方法,并且在复发时,通过自然开口对梗阻腺体的主导管和实质进行功能保留可使涎腺镜进入。将经口入路与其他微创、保守手术方法相结合可确保大多数患者症状缓解及唾液腺导管系统通畅。